PERIANAL CONDYLOMAS: CLINICAL SYMPTOMS, DIAGNOSIS AND TREATMENT OPPORTUNITIES

Cover Page


Cite item

Full Text

Abstract

The article discusses current data on the prevalence and clinical manifestations of papyllomavirus infection. Burning issues of diagnosis and treatment are delineated. Experience-based recommendations on the diagnosis and treatment of papyllomavirus infection are presented.

About the authors

E. V. Antipova

City Clinical Hospital No. 24 of the Moscow City Health Department; 10 Pistsovaya ul., Moscow, 127015, Russian Federation

Author for correspondence.
Email: lenakdo@mail.ru
MD, PhD, the Head of the Coloproctology diagnostic department Россия

V. A. Filippenko

City Clinical Hospital No. 24 of the Moscow City Health Department; 10 Pistsovaya ul., Moscow, 127015, Russian Federation

Email: fake@neicon.ru
the Head of the Admission and Diagnostic Department Россия

E. V. Kuznetsova

City Clinical Hospital No. 24 of the Moscow City Health Department; 10 Pistsovaya ul., Moscow, 127015, Russian Federation

Email: fake@neicon.ru
coloproctologist, Coloproctology diagnostic department Россия

E. A. Fabrikova

City Clinical Hospital No. 24 of the Moscow City Health Department; 10 Pistsovaya ul., Moscow, 127015, Russian Federation

Email: fake@neicon.ru
coloproctologist, Coloproctology diagnostic department Россия

D. L. Davidovich

City Clinical Hospital No. 24 of the Moscow City Health Department; 10 Pistsovaya ul., Moscow, 127015, Russian Federation

Email: denisdavidovich@mail.ru
MD, PhD, coloproctologist, Coloproctology diagnostic department Россия

A. Ya. Solomka

City Clinical Hospital No. 24 of the Moscow City Health Department; 10 Pistsovaya ul., Moscow, 127015, Russian Federation

Email: fake@neicon.ru
coloproctologist, Coloproctology diagnostic department Россия

References

  1. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis. 2005;191(2):182–92.
  2. Кулаков ВИ, Савельева ГМ, Манухин ИБ, ред. Гинекология: национальное руководство. М.: ГЭОТАР-Медиа; 2007. 1072 с.
  3. (Kulakov VI, Savel’evа GM, Manukhin IB, editors. Gynecology: national guideline. Moscow: GEOTAR-Media; 2007. 1072 р. Russian).
  4. Дубенский ВВ, Максимов МО. Современный взгляд на диагностику и лечение урогенитальной папилломавирусной инфекции. Российский журнал кожных и венерических болезней. 2001;(1):51–6.
  5. (Dubenskiy VV, Maksimov MO. [Modern approaches to the diagnosis and treatment of urogenital papillomavirus infection]. Rossiyskiy zhurnal kozhnykh i venericheskikh bolezney. 2001;(1):51–6. Russian).
  6. Роговская С.И. Папилломавирусная инфекция и патология шейки матки. М.: ГЭОТАР-Медиа; 2009. 198 с.
  7. (Rogovskaya S.I. Papillomavirus infection and disorders of uterine cervix. Moscow: GEOTAR-Media; 2009. 198 p. Russian).
  8. Jansen KU, Shaw AR. Human papillomavirus vaccines and prevention of cervical cancer. Annu Rev Med. 2004;55:319–31.
  9. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997;102(5A):3–8.
  10. Rowhani-Rahbar A, Carter JJ, Hawes SE, Hughes JP, Weiss NS, Galloway DA, Koutsky LA. Antibody responses in oral fluid after administration of prophylactic human papillomavirus vaccines. J Infect Dis. 2009;200(9):1452–5.
  11. Tortolero-Luna G. Epidemiology of genital human papillomavirus. Hematol Oncol Clin North Am. 1999;13(1):245–57.
  12. Статистические материалы: заболеваемость, ресурсы и деятельность кожно-венерологических учреждений в 2008– 2009 гг. М.; 2010. 119 с.
  13. (Disease incidence, resources and activities of dermatovenerological facilities: statistics 2008–2009. Moscow; 2010. 119 р. Russian).
  14. Palefsky J. Efficacy of the quadrivalent HPV vaccine to prevent anal intraepithelial neoplasia among young men who have sex with men. 26th International Papillomavirus Conference; July 3–8 2010; Montreal, Canada. 2010.
  15. Dunne EF, Markowitz LE, Hariri S, Datta D, Saraiya M, Unger ER. Strategies to monitor HPV vaccine impact in USA. Abstracts, 25 HPV conference. Sweeden 2009; 2701.
  16. Franco L, Villa L, Richardson H. Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. In: Franco EL, Monsonego J, editors. New developments in cervical cancer screening and prevention. Oxford: Blackwell Science; 1997. p. 14–22.
  17. Soper DE. Genitourinary infections and sexually transmitted diseases. In: Berek J, editor. Novak’s Gynecology. 13th ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 453–70.
  18. Bosch F, Gissman L, Kocken M. European Consensus Statement on “HPV Vaccination and Colposcopy” Prepared on behalf of the European Federation for Colposcopy. EFC conference. Berlin; 2010. p. 97–100.
  19. Аруин ЛИ, Капуллер ЛЛ, Исаков ВА. Морфологическая диагностика болезней желудка и кишечника. М.: Триада-Х; 1998. 496 c. (Aruin LI, Kapuller LL, Isakov VA. Morphological diagnosis of gastric and intestinal diseases. Moscow: Triada-Х; 1998. Russian).
  20. Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health. 2004;36(1):11–9.
  21. Sexually transmitted infections quarterly report: Anogenital warts and HSV infection in England and Wales. CDR Wkly. 2001;11(35): 546–8.
  22. Wiley DJ, Douglas J, Beutner K, Cox T, Fife K, Moscicki AB, Fukumoto L. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis. 2002;35(Suppl 2):S210–24.
  23. Brotherton J, Fridman M, Saville M, Gertig D. First indication of a possible impact on cervical abnormalities following a national HPV vaccination program in Victoria, Australia. Updated July 2010. Abstract # 508, presented at IPV 2010, Montreal.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Antipova E.V., Filippenko V.A., Kuznetsova E.V., Fabrikova E.A., Davidovich D.L., Solomka A.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies